Lifespan opens new clinical trial site in collaboration with TriSalus

PROVIDENCE – Lifespan Corp. is activating a new clinical trial site at Rhode Island Hospital in collaboration with TriSalus Life Sciences, an oncology therapeutics company. The new Pressure-Enabled Regional Immuno-Oncology clinical trial will study a new potential treatment for patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma. “The activation of this clinical trial site and continued…

Register to keep reading or subscribe today and receive unlimited access.
Register Now Already a Subscriber? Login now

If you have already logged in and are still seeing this message, please refresh the page as your browser is caching the old content.

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.